(Q34232396)

31 July 2017

Interferon-alpha-induced acute renal allograft rejection (English)

1 reference

31 July 2017

8

T Starzl

1 reference

31 July 2017

M Magnone

1

1 reference

31 July 2017

J L Holley

2

1 reference

31 July 2017

R Shapiro

3

1 reference

31 July 2017

V Scantlebury

4

1 reference

31 July 2017

J McCauley

5

1 reference

31 July 2017

M Jordan

6

1 reference

31 July 2017

C Vivas

7

1 reference

31 July 2017

J P Johnson

9

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 April 1995

1 reference

31 July 2017

1 reference

31 July 2017

59

1 reference

31 July 2017

1068-1070

1 reference

31 July 2017

7

1 reference

Immunophilins in protein folding and immunosuppression.

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2962569

Recombinant leucocyte interferon A induces steroid-resistant acute vascular rejection episodes in renal transplant recipients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2962569

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2962569

Interferons and interferon inducers in cancer treatment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2962569

Double-blind, placebo-controlled trial of human lymphoblastoid interferon prophylaxis of cytomegalovirus infection in renal transplant recipients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2962569

Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2962569

Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2962569

Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients

6 July 2018

1 reference

12 December 2020

The alpha-interferon system in patients undergoing renal transplantation and treated with cyclosporine and prednisone

1 reference

12 December 2020

The effects of interferon-alpha/beta in a model of rat heart transplantation

1 reference

12 December 2020

Gamma interferon synthesis by human thymocytes and T lymphocytes inhibited by cyclosporin A

1 reference

12 December 2020

Acute interstitial nephritis with the nephrotic syndrome following recombinant leukocyte a interferon therapy for mycosis fungoides

1 reference

12 December 2020

Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. II. Inhibition of the production of IL-2 and gamma-IFN, but not B cell-stimulating factor 2

1 reference

12 December 2020

Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alpha treatment in renal transplant recipients. Cytomegalovirus infection prophylaxis leading to an increased incidence of irreversible rejections

1 reference

12 December 2020

10.1097/00007890-199504150-00030

Identifiers

DOI

1 reference

31 July 2017

1 reference

31 July 2017

1 reference